Remove about global-press-office
article thumbnail

RSVpreF vaccine candidate effective against respiratory syncytial virus

Hospital Pharmacy Europe

Pfizer’s vaccine candidate RSVpreF for respiratory syncytial virus (RSV) showed a high level of efficacy in older patients with more severe lower respiratory tract illness which was defined by three or more RSV-associated symptoms according to a press release from the company. g RSVpreF or placebo in a 1:1 ratio.

article thumbnail

Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence

pharmaphorum

Located on the outskirts of the historic Italian city – home to Verdi and myriad architectural gems – the press launch and tour of the €85 million Chiesi development was a quintessentially Italian affair, based out of Chiesi’s San Leonardo production site. The situation was reversed only 25 years ago.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma improves HCP engagement during COVID-19 – report

pharmaphorum

The Accenture survey of 720 general practitioners, oncologists, cardiologists and immunologists globally found that this is in turn helping HCPs better serve patients. Indeed, 43% of HCPs said they are currently restricting who can enter the office for professional reasons (i.e. The impact on launch. no pharmaceutical reps).

article thumbnail

The post-Covid New Normal: a golden opportunity for the NHS?

pharmaphorum

While Whitty deftly deferred a question around the impact of Brexit on funding to his government colleagues, he does see supporting the workforce as the most pressing priority, along with the need to manage press around the NHS as it innovates. About the author. Accelerating access for patients. A golden age? Absolutely.

article thumbnail

Will people be left behind by the digital health revolution?

pharmaphorum

The reason why this has become such a pressing issue is due to the rapid growth of digital healthcare solutions, which now include mobile healthcare applications, digital therapeutics, health information technology, telehealth and telemedicine, personalised medicine, and wearable devices. Whole system approach.

144
144
article thumbnail

Building agile partner relationships at a vaccine-focused biotech

pharmaphorum

About the interviewees. Lee Taurman – Executive Vice President, Global Head of Full-Service Commercial, Syneos Health. Commercial Innovation leverages our broad commercial and clinical capabilities to develop integrated solutions that address our clients most pressing needs. About Syneos Health.

article thumbnail

Covid-19 vaccines targeting Omicron variants expected to be ready for this autumn

Pharmaceutical Technology

1, Moderna said in its recent press release. The FDA did not respond to a comment request from Pharmaceutical Technology about any review plans. I would be very surprised if they selected something other than the Omicron [variants] given where we are right now globally in the pandemic,” Kulkarni notes.

Vaccines 105